Media Database
>
Ciara Linnane

Ciara Linnane

Companies & Investing Editor at MarketWatch

Contact this person
Email address
c*****@*******.comGet email address
Influence score
66
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Business
  • Finance & Banking Services

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

marketwatch.com

This could be Tesla’s next plan to recoup China market share

Tesla has lost share to Chinese competitors, while Elon Musk’s political activities have led to steep declines in Tesla sales in Europe.
marketwatch.com

Kroger CEO Rodney McMullen ousted following probe of personal conduct

“Mr. McMullen’s conduct is not related to the company’s financial performance, operations or reporting, and it did not involve any Kroger associates,” the company said.
marketwatch.com

Here’s when Vital Farms predicts it will be selling more eggs

The company will continue to invest in brands and supply-chain capabilities as it targets $1 billion in sales by 2027.
marketwatch.com

Hormel’s stock boosted by revenue beat, though challenges lie ahead...

The company said it continues to “recover from the snack nuts supply disruption” that impacted Planters nuts.
marketwatch.com

Here’s why the U.S. is not working to vaccinate birds against avian...

More than 160 million birds have been culled during the bird-flu outbreak that started in 2022. So why is the U.S. not vaccinating chickens?
marketwatch.com

Bloomin’ Brands’ stock slides to pre-pandemic levels as revenue mis...

The parent company of Outback Steakhouse swings to a loss and offered soft guidance for 2025 amid continued pressure on fast-casual dining.
marketwatch.com

Eli Lilly to spend $27 billion to expand U.S. manufacturing with fo...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.
marketwatch.com

Snowflake’s stock soars as revenue and guidance cheer up investors

Snowflake shares soared in after-hours trade Wednesday, after the company’s fiscal fourth-quarter revenue topped estimates and it offered upbeat guidance for fiscal 2026.
marketwatch.com

Why this newly public biotech could become a force in obesity treat...

Metsera’s GLP-1 peptide has a long half-life, meaning it could be administered once a month. The company is ready to scale up.
marketwatch.com

Eli Lilly cuts price of weight-loss drug Zepbound as competition he...

The drug company is calling on insurers and federal programs to cover obesity as a chronic disease.
marketwatch.com

These 3 healthcare stories are spooking investors. But they shouldn...

Rumors of cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth have investors focused on the wrong things, one analyst says.